Global genetic products developer and manufacturer
) recently announced a world-wide collaboration with Leica
Microsystems, a leading manufacturer of microscopes and other
scientific instruments. The collaboration will allow QuantiGene
ViewRNA ISH Tissue Assay produced by Affymetrix to undergo
automation on the Leica BOND RX staining platform for research
Affymetrix is rigorously implementing its strategy of improving
its Panomics Solution product lines. Last month, Affymetrix
announced a global distribution agreement with ScreenCell, a
medical devices company which specializes in isolating rare
Management at Affymetrix believes that collaboration with Leica
will bring out the true potential of single-copy RNA analysis. It
also believes that the partnership will validate unique companion
tests and stimulate the exposition of new drugs.
The company is expanding its customer base through new product
launches and strategic alliances. Moreover, it is pursuing a number
of strategies (including expansion into new markets) aimed at its
Management at Leica Microsystems is optimistic about improving
standard and quality of patient care after the collaboration. The
partnership will support the development and discovery process for
new drugs. It will also reduce time taken for research and
associated costs, thereby providing new treatment ahead of
The company's QuantiGene product portfolio provides quantitative
gene expression analysis. With automation of the QuantiGene ViewRNA
ISH Tissue Assay on the Leica BOND RX, researchers will have an
automated solution for drug discovery, translation research, and
development of new companion diagnostic tests for personalized
medicine on a regular basis.
Affymetrix will provide the complete staining kit comprising the
QuantiGene ViewRNA staining protocol and the Leica BOND RX. The
QuantiGene ViewRNA ISH Tissue Assay on the Leica BOND RX staining
platform kit will serve researchers in the discovery market
starting from the third quarter of 2012.
Affymetrix is a leading provider of microarray-based products
and services to the global research community. Along with
), it is one of the two major providers of microarray technologies,
primarily used in the field of genetic research.
AFFYMETRIX INC (AFFX): Free Stock Analysis
ILLUMINA INC (ILMN): Free Stock Analysis Report
To read this article on Zacks.com click here.